Regeneron Pharmaceuticals Inc. has found itself in the spotlight after President Donald Trump was treated with the company’s experimental antibody treatment for Covid-19, just days after the unveiling of promising preliminary trial results.
The Tarrytown, New York-based biotechnology company said it had provided a single high dose of the drug for Trump after receiving a compassionate-use request from his doctors. Trump is at higher risk of severe Covid-19 complications due to his age and clinical obesity.
